NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

Is It Time To Reconsider T. Rowe Price (TROW) After Years Of Weak Share Returns?

If you are considering whether T. Rowe Price Group at around US$106 offers good value right now, this article explains what the current price might be implying and how that compares with different valuation checks. The stock has returned 3.5% over the last 7 days, 1.4% over the last 30 days, 1.3% year to date, and shows a 1% decline over 1 year and a 16% decline over 5 years. These figures can shape how you think about its risk and opportunity today. Recent attention around T. Rowe Price...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Assessing Intellia Therapeutics (NTLA) Valuation After FDA Clinical Hold On Lead Gene Editing Trial

Why Intellia’s recent clinical hold matters for investors Intellia Therapeutics (NTLA) recently halted dosing and patient enrollment in its late stage MAGNITUDE studies after a patient death linked to severe liver side effects, prompting an FDA clinical hold on its lead therapy candidate. See our latest analysis for Intellia Therapeutics. The clinical hold comes after a steep 90 day share price return decline of 58.69%, leaving Intellia at US$10.13. That setback contrasts with a positive year...
NasdaqGS:MDLZ
NasdaqGS:MDLZFood

Is Mondelez International (MDLZ) Offering Value After Recent Share Price Weakness

If you are wondering whether Mondelez International's current share price offers good value or is pricing in too much optimism, you are not alone. The stock recently closed at US$51.51, with returns of a 4.3% decline over the last 7 days, a 5.9% decline over 30 days and a 4.0% decline year to date, adding to an 8.8% decline over 1 year and a modest 1.8% gain over 5 years. Recent coverage around Mondelez has focused on its role as a large global snacks and confectionery company, with...
ASX:LYC
ASX:LYCMetals and Mining

Assessing Lynas Rare Earths (ASX:LYC) Valuation After China’s Latest Export Restrictions

China’s latest export restrictions on military use items to Japan, which include rare earth related products, have pushed Lynas Rare Earths (ASX:LYC) back into focus for investors watching non Chinese supply chains. See our latest analysis for Lynas Rare Earths. The latest China export curbs arrive as Lynas Rare Earths trades at A$14.24, with a 7 day share price return of 14.47% and a 30 day share price return of 10.13%. This follows earlier weakness that left the 90 day share price return at...
TSX:TRI
TSX:TRIProfessional Services

Will Thomson Reuters’ AI Shift Redefine Its Core Moat for Investors (TSX:TRI)?

Thomson Reuters recently announced that it released its fourth-quarter and full-year 2025 results and hosted an earnings webcast on February 5, 2026, featuring CEO Steve Hasker and CFO Mike Eastwood for investors and analysts. Alongside this earnings update, growing attention on Thomson Reuters’ AI-enhanced legal, tax, and compliance platforms is underscoring its role as a core digital workflow provider for professional clients. We’ll now examine how this renewed focus on Thomson Reuters’...